Association between hepatitis B virus (HBV) reactivation and recurrence of hepatocellular carcinoma (HCC) following direct-acting antiviral (DAA) treatment for hepatitis C.
Not Applicable
- Conditions
- Hepatitis C, Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000031368
- Lead Sponsor
- Matsuyama Red Cross Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
none.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HBs/HBc antibodies and HBV DNA before and after DAA.
- Secondary Outcome Measures
Name Time Method